The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma

NCT05738447 ·Status: UNKNOWN ·Phase: PHASE1

Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels

NCT00814242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma

NCT06311929 ·Status: RECRUITING ·Phase: PHASE4

Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma

NCT06339424 ·Status: RECRUITING ·Phase: PHASE2

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

NCT02728193 ·Status: COMPLETED ·Phase: NA

Ablation Combined With PD-1 in HCC: Phase II Study

NCT04652440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC

NCT06742424 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

NCT06096896 ·Status: ACTIVE_NOT_RECRUITING

Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

NCT02634502 ·Status: UNKNOWN ·Phase: PHASE2

Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy

NCT05057104 ·Status: UNKNOWN

Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma

NCT06644430 ·Status: RECRUITING

The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma

NCT05760430 ·Status: UNKNOWN ·Phase: PHASE2

Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC

NCT06461936 ·Status: ACTIVE_NOT_RECRUITING

Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular Carcinoma

NCT06715072 ·Status: NOT_YET_RECRUITING

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

NCT06157060 ·Status: RECRUITING

RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)

NCT04193696 ·Status: UNKNOWN ·Phase: PHASE2

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

NCT06423144 ·Status: NOT_YET_RECRUITING

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

NCT05025592 ·Status: UNKNOWN

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions

NCT06881446 ·Status: COMPLETED

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

NCT04165174 ·Status: UNKNOWN ·Phase: PHASE2

Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer

NCT01126645 ·Status: COMPLETED ·Phase: PHASE2

Observational Study on Patients With Hepatobiliary Tumors

NCT04637048 ·Status: UNKNOWN

Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

NCT05761717 ·Status: UNKNOWN ·Phase: NA

Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial

NCT04814030 ·Status: UNKNOWN ·Phase: PHASE2

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

NCT02557503 ·Status: UNKNOWN ·Phase: PHASE4